The role of matrix metalloproteinases in pathogenesis, diagnostics, and treatment of human prostate cancer

Department of Urology and Urological Oncology, Cardinal Stefan Wyszynski Voivodship Specialist Hospital, Independent Public Healthcare, Lublin, Poland

Jarosław Bryda

Department of Veterinary Hygiene, Voivodship Veterinary Inspectorate, Lublin, Poland

Sławomir Wątroba

watrobaslaw@gmail.com

Department of Neonatology and Neonatal Intensive Care Unit, Independent Public Healthcare, Puławy, Poland

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/ahem-2023-0002 | Journal eISSN: 1732-2693

Journal RSS Feed

Language: English

Page range: 9 - 20

Submitted on: Feb 26, 2022

Accepted on: Nov 15, 2022

Published on: Mar 1, 2023

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

extracellular matrix,

matrix metalloproteinases,

prostatic neoplasms,

prostate-specific antigen,

prostatic hyperplasia

Related subjects:

Life sciences,

Molecular biology,

Microbiology and virology,

Medicine,

Basic medical science,

Immunology

© 2023 Tomasz Wiśniowski, Jarosław Bryda, Sławomir Wątroba, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 77 (2023): Issue 1 (January 2023)